International Team Discovers Childhood Asthma Gene

An international team of researchers, including several investigators from The Children’s Hospital of Philadelphia’s Center for Applied Genomics, recently discovered a gene associated with a high risk of severe childhood asthma. The specific gene variant may be an actual cause of this form of asthma, a leading cause of hospitalization in young children......

Read more here: research.chop.edu

------------------------------------------------------

Kyorin Pharmaceutical to market flutiform for asthma, COPD in Japan

Skyepharma, an expert oral and inhalation drug delivery company, has launched flutiform in Japan following agreement on pricing reimbursement. Flutiform is being marketed in Japan by Skyepharma's licensing partner, Kyorin Pharmaceutical Co, Ltd. as "flutiform 50 Aerosol" (56 inhalations) and "flutiform 125 Aerosol" (56 inhalations) for the treatment of patients aged 16 years and over with bronchial asthma. A milestone of several million US dollars was received from Kyorin following regulatory approval in September 2013 and Skyepharma is entitled to high-mid single digit royalties on net sales.....

Read more here: pharmabiz.com

------------------------------------------------------

Asthma Attacks Among Persons with Current Asthma — United States, 2001–2010

Introduction
Asthma is a chronic inflammatory disorder of the airways that is characterized by episodic and reversible airflow obstruction, airway hyper-responsiveness, and underlying inflammation. Common asthma symptoms include wheezing, coughing, and shortness of breath (1). With correct treatment and avoidance of exposure to environmental allergens and irritants that are known to exacerbate asthma, the majority of persons who have asthma can expect to achieve optimal symptom control (2).....

Read more here: cdc.gov